PMID: 8606801Nov 1, 1995Paper

Transport of histamine by vesicular monoamine transporter-2

Neuropharmacology
A Merickel, R H Edwards

Abstract

Histamine mediates signalling by a wide range of neural and non-neural cells including mast cells. Like other biogenic amines, histamine is released from specialized secretory vesicles and requires transport from the cytoplasm into these vesicles. Of the two vesicular monoamine transporters, histamine potently inhibits 3H-serotonin transport by one (VMAT2) but not the other (VMAT1). In addition, histamine-containing cells in both neural and non-neural cells express VMAT2. However, histamine lacks the hydroxyl groups generally considered necessary for recognition as a substrate by the vesicular monoamine transporters. Using a heterologous expression system, we now report that VMAT2 not only shows inhibition by histamine but also transports 3H-histamine. Interestingly, histamine differs from other monoamine transmitters and does not inhibit 3H-reserpine binding to VMAT2, indicating interaction at a distinct site. Surprisingly, reserpine inhibits histamine transport with much less potency than serotonin transport, suggesting a different transport mechanism. However, replacement of serines in the third transmembrane domain of VMAT2 that have been shown to be essential for recognition of other monoamines also eliminate 3H-histamine ...Continue Reading

References

Feb 1, 1975·British Journal of Pharmacology·M Da PradaA Pletscher
Oct 1, 1992·Current Opinion in Neurobiology·R H Edwards
Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·Y LiuR H Edwards
Nov 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J D EricksonB J Hoffman
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S KitayamaG R Uhl
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M YamashitaH Wada
Jul 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·I GantzT Yamada
Nov 1, 1985·Naunyn-Schmiedeberg's Archives of Pharmacology·G KoboldA Burger
Nov 23, 1973·Brain Research·A PletscherK H Berneis
Jun 1, 1981·European Journal of Biochemistry·D Scherman, J P Henry
Oct 27, 1995·The Journal of Biological Chemistry·A MerickelR H Edwards
Jun 1, 1994·Journal of Neurochemistry·S Schuldiner

❮ Previous
Next ❯

Citations

Dec 17, 2009·Journal of Molecular Modeling·Katja Perdan-PirkmajerMojca Krzan
Mar 5, 2009·Molecular Neurobiology·Thomas S Guillot, Gary W Miller
Feb 6, 2004·Journal of Neuroscience Methods·Janet WhitleyJoseph A Near
Jan 14, 2000·European Journal of Pharmacology·E LindströmR Håkanson
Sep 12, 1998·Brain Research. Developmental Brain Research·S R HanssonE Mezey
Dec 5, 1997·Brain Research. Molecular Brain Research·N Takahashi, G Uhl
May 20, 1998·Neurochemistry International·J P HenryB Gasnier
Jul 5, 2003·Journal of Chemical Neuroanatomy·Tiina Kaisa Kukko-Lukjanov, Pertti Panula
Aug 5, 1998·British Journal of Pharmacology·S Al-Damluji, I J Kopin
Jan 5, 2000·Proceedings of the National Academy of Sciences of the United States of America·E R TravisR M Wightman
Dec 17, 2009·The Journal of Biological Chemistry·Yael Gros, Shimon Schuldiner
Dec 17, 2010·Zebrafish·Caio Maximino, Anderson Manoel Herculano
Nov 7, 2008·Human Reproduction Update·Stefan R HanssonBertil Casslén
Jan 1, 1997·Annual Review of Neuroscience·Y Liu, R H Edwards
Oct 19, 2013·Journal of Mammary Gland Biology and Neoplasia·Aaron M MarshallNelson D Horseman
Jun 7, 2014·Nature Reviews. Immunology·Sara Wernersson, Gunnar Pejler
Apr 4, 2013·Neurochemical Research·Katja Perdan-PirkmajerMojca Krzan
Dec 10, 2013·European Journal of Immunology·Jenny Hallgren, Michael F Gurish
Sep 5, 2013·European Journal of Immunology·Shunsuke NakazawaSatoshi Tanaka
Dec 9, 2014·Acta Physiologica·M Sundvik, P Panula
May 16, 2012·Neurochemistry International·Katja Perdan-PirkmajerMojca Kržan
Mar 29, 2014·Blood·Efthymios MotakisUNKNOWN FANTOM consortium
Dec 3, 2014·Frontiers in Immunology·Tae Chul MoonMarianna Kulka
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan
Oct 19, 2016·Molecular Pharmacology·Gustavo Nieto-AlamillaJosé-Antonio Arias-Montaño
Dec 13, 2017·Theoretical Biology & Medical Modelling·Janet BestMichael Reed
Dec 19, 2017·Frontiers in Immunology·Helene MöllerhermKatja Branitzki-Heinemann
Jul 16, 2008·Physiological Reviews·Helmut L HaasOliver Selbach
Nov 1, 2018·Molecular Psychiatry·Jun OhLea T Grinberg
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S M Parsons
Dec 2, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E Weihe, L E Eiden
Oct 25, 2017·Frontiers in Neural Circuits·Clément Vitrac, Marianne Benoit-Marand

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.